Bayer Healthcare in $97.5 million kickback settlement
Diabetic supply maker Bayer Healthcare has agreed to pay $97.5 million to settle allegations that it paid kickbacks to several diabetic suppliers and caused them to submit false Medicare claims, the U.S. Justice Department said. Bayer agreed to enter into a corporate integrity agreement—which allows companies to continue in the federal Medicare program while requiring steps to safeguard against fraudulent behavior—as part of the settlement. The settlement resolves allegations that Bayer paid 11 diabetic suppliers to convert their patients to Bayer products from competitors' products. It pertains to Medicare claims submitted by the companies from 1998 to 2007.
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- Carondelet to Pay $35M to Settle Fraud Allegations
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- CA Powers Up $80M HIE to 'Create Value in the Data'
- 3 Traits Personality Assessments Can't Reveal